<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Washington,
D.</B></FONT><B>C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of Earliest Event Reported):
January 12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_009.jpg" ALT="" STYLE="height: 156px; width: 177px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; width: 100%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Dr. Foods, Inc.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 29%; line-height: 106%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 106%">&nbsp;</TD>
    <TD STYLE="width: 41%; line-height: 106%">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 106%">&nbsp;</TD>
    <TD STYLE="width: 28%; line-height: 106%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif"><B>Nevada</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 106%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif"><B>000-56277</B>&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 106%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif"><B>00-0000000</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(state or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 106%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(Commission File Number)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 106%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(IRS Employer Identification Number)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 47%; line-height: 106%">&nbsp;</TD>
    <TD STYLE="width: 10%; line-height: 106%">&nbsp;</TD>
    <TD STYLE="width: 43%; line-height: 106%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>3F K&rsquo;s Minamiaoyama</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>6-6-20 Minamiaoyama, Minato-ku,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Tokyo 107-0062, Japan</B></P></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; line-height: 106%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif"><B>107-0062</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(address of principal executive offices)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 106%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(zip code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; line-height: 106%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; padding-bottom: 8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif"><B>81-90-6002-4978</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(registrant&rsquo;s telephone number, including area code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; line-height: 106%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center; line-height: 115%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><B>N/A</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">(former name or former mailing address, if changed since last report)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 106%"><FONT STYLE="font: 10pt/106% Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 11.25pt 0 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect; 230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Emerging growth company&nbsp;&nbsp;[X]</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;[ &nbsp;&nbsp;]&nbsp;</FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>


<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: #A0A0A0">

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&ldquo;We&rdquo;, &ldquo;Us&rdquo;, and or &ldquo;The Company&rdquo;
refer to Dr. Foods, Inc.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: left; text-indent: 0px"><B>Forward
Looking Statements</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: left; text-indent: 0px"><B>&nbsp;</B></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: left; text-indent: 0px">This
Current Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, that involve risks, uncertainties, and assumptions that are difficult to predict.
All statements other than statements of historical fact contained in this Current Report, including statements regarding future events,
our future financial performance, business strategy, and plans and objectives of management for future operations, are forward-looking
statements. We have attempted to identify forward-looking statements by terminology including &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;can,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;may,&rdquo; &ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo; or &ldquo;should,&rdquo; or the negative of these
terms or other comparable terminology. The forward-looking statements made herein are based on the Company&rsquo;s current expectations.
Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important
factors, including, without limitation, its limited operating history, competitive factors in the Company&rsquo;s industry and market,
and other general economic conditions. The forward-looking statements made herein are based on the Company&rsquo;s current expectations,
assumptions, and projections, which could provide to be incorrect. The forward-looking statements made herein speak only as of the date
of this Current Report and the Company undertakes no obligation to update publicly such forward-looking statements to reflect subsequent
events or circumstances, except as otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white"><B>Item 8.01 Other Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On January 12, 2022, Dr. Foods, Inc., a Nevada Company, Mama Foods
Co., Ltd., a Japan Company, and White Knight Co., Ltd., a Japan Company entered into a non-definitive agreement, a &ldquo;Letter of
Intent&rdquo;, whereas it is proposed that Dr. Foods, Inc., will acquire 100% of the controlling interest of Mama Foods Co., Ltd.
from White Knight Co., Ltd. in exchange for $500,000 coupled with the issuance of 19,500,000 shares of restricted Preferred Stock to
White Knight Co., Ltd. The issuance of shares shall be subject to the rules and limitations set forth by the Securities Act Rule
144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">It should be noted that the terms, conditions, and consideration to
be exchanged pursuant to a future definitive agreement for an acquisition of Mama Foods Co., Ltd. by Dr. Foods, Inc. from White
Knight Co., Ltd. may be changed, and or renegotiated, if agreed upon by all parties. If this is to occur prior to entering into a
binding definitive agreement, any such material change(s) to the letter of intent will be made public by Dr. Foods, Inc. via a Form
8-K it will file with the Securities and Exchange Commission. The Letter of Intent is included in its entirety herein as Exhibit
10.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt">Mama Foods, Co., Ltd. (&ldquo;Mama Foods&rdquo;) is a food
company founded in Japan in 1958, currently offering customers in Japan wholesale and retail products centering on Japanese side
dishes, from chilled foods to packed and sterilized food. Mama Foods uses ingredients carefully taken from natural kelp and bonito
without adding any chemical seasonings, preservatives, coloring agents, etc. Mama Foods has two existing &ldquo;in house&rdquo;
production facilities and produces 100% of its current product offerings. From time to time, it also produces products of other
third parties, including certain products offered for sale by Next Meats Co., Ltd., such as &ldquo;Next Kalbi 2.0&rdquo;, a boneless
short rib made from meat substitutes. Currently, Mama Foods employs approximately 43 individuals. In 2021, White Knight Co., Ltd.
acquired 100% of Mama Foods from its prior controller, in exchange for approximately 1 million USD. The current website for Mama
Foods, which includes additional information, can be found here: mama-foods.com/en/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0">The sole shareholder of Mama
Foods Co., Ltd. is White Knight Co., Ltd. White Knight Co., Ltd. is owned and controlled by Koichi Ishizuka. Koichi Ishizuka is Chief
Executive Officer, Chief Financial Officer, and Director of Dr. Foods, Inc., Mama Foods Co., Ltd. and White Knight Co., Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01  Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: center; text-indent: 0px"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; font: 11pt Calibri, Helvetica, sans-serif; text-decoration: initial; width: 1224px; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 15.69px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 14.13px"><B>Exhibit Number</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 86%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 15.69px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 14.13px"><B>&nbsp;Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204, 238, 255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 15.69px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 14.13px">10.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 15.69px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 14.13px">Letter
    of Intent (1)</FONT></TD></TR>
  </TABLE>
<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-indent: 0.5in">&nbsp;</P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-indent: 0px"></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-indent: 0px">(1)
Filed herewith.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<HR SIZE="3" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: #A0A0A0">

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report to be signed on its behalf by the
undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 43%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 57%; line-height: 107%; font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Dr.
    Foods, Inc.</FONT></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt"></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Dated:
    &nbsp;January 13, 2022</FONT></TD>
    <TD STYLE="text-decoration: underline; padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><U> <I>/s/
    Koichi Ishizuka </I></U></FONT></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt">
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Koichi Ishizuka</P>
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>





</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8k11222.htm", "description": "FORM 8-K", "secsgml_size_bytes": 23308}]
{"company-data": {"conformed-name": "Dr. Foods, Inc.", "cik": "0001857910", "assigned-sic": "6770", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-56277", "film-number": "22527935"}, "business-address": {"street1": "3F K MINAMIAOYAMA", "street2": "6-6-20 MINAMIAOYAMA", "city": "TOKYO", "state": "M0", "zip": "107-0062", "phone": "81-90-6002-4978"}, "mail-address": {"street1": "3F K MINAMIAOYAMA", "street2": "6-6-20 MINAMIAOYAMA", "city": "TOKYO", "state": "M0", "zip": "107-0062"}, "former-company": {"former-conformed-name": "Catapult Solutions, Inc.", "date-changed": "20210420"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.
C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
January 12, 2022
Dr. Foods, Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-56277
00-0000000
(state or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification Number)
3F K's Minamiaoyama
6-6-20 Minamiaoyama, Minato-ku,
Tokyo 107-0062, Japan
107-0062
(address of principal executive offices)
(zip code)
81-90-6002-4978
(registrant's telephone number, including area code)
N/A
(former name or former mailing address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[   ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  [X]
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [   ]
"We", "Us", and or "The Company"
refer to Dr. Foods, Inc.
Forward
Looking Statements
This
Current Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, that involve risks, uncertainties, and assumptions that are difficult to predict.
All statements other than statements of historical fact contained in this Current Report, including statements regarding future events,
our future financial performance, business strategy, and plans and objectives of management for future operations, are forward-looking
statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes,"
"can," "continue," "could," "estimates," "expects," "intends,"
"may," "plans," "potential," "predicts," or "should," or the negative of these
terms or other comparable terminology. The forward-looking statements made herein are based on the Company's current expectations.
Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important
factors, including, without limitation, its limited operating history, competitive factors in the Company's industry and market,
and other general economic conditions. The forward-looking statements made herein are based on the Company's current expectations,
assumptions, and projections, which could provide to be incorrect. The forward-looking statements made herein speak only as of the date
of this Current Report and the Company undertakes no obligation to update publicly such forward-looking statements to reflect subsequent
events or circumstances, except as otherwise required by law.
Item 8.01 Other Events.
On January 12, 2022, Dr. Foods, Inc., a Nevada Company, Mama Foods
Co., Ltd., a Japan Company, and White Knight Co., Ltd., a Japan Company entered into a non-definitive agreement, a "Letter of
Intent", whereas it is proposed that Dr. Foods, Inc., will acquire 100% of the controlling interest of Mama Foods Co., Ltd.
from White Knight Co., Ltd. in exchange for $500,000 coupled with the issuance of 19,500,000 shares of restricted Preferred Stock to
White Knight Co., Ltd. The issuance of shares shall be subject to the rules and limitations set forth by the Securities Act Rule
144.
It should be noted that the terms, conditions, and consideration to
be exchanged pursuant to a future definitive agreement for an acquisition of Mama Foods Co., Ltd. by Dr. Foods, Inc. from White
Knight Co., Ltd. may be changed, and or renegotiated, if agreed upon by all parties. If this is to occur prior to entering into a
binding definitive agreement, any such material change(s) to the letter of intent will be made public by Dr. Foods, Inc. via a Form
8-K it will file with the Securities and Exchange Commission. The Letter of Intent is included in its entirety herein as Exhibit
10.1.
Mama Foods, Co., Ltd. ("Mama Foods") is a food
company founded in Japan in 1958, currently offering customers in Japan wholesale and retail products centering on Japanese side
dishes, from chilled foods to packed and sterilized food. Mama Foods uses ingredients carefully taken from natural kelp and bonito
without adding any chemical seasonings, preservatives, coloring agents, etc. Mama Foods has two existing "in house"
production facilities and produces 100% of its current product offerings. From time to time, it also produces products of other
third parties, including certain products offered for sale by Next Meats Co., Ltd., such as "Next Kalbi 2.0", a boneless
short rib made from meat substitutes. Currently, Mama Foods employs approximately 43 individuals. In 2021, White Knight Co., Ltd.
acquired 100% of Mama Foods from its prior controller, in exchange for approximately 1 million USD. The current website for Mama
Foods, which includes additional information, can be found here: mama-foods.com/en/
The sole shareholder of Mama
Foods Co., Ltd. is White Knight Co., Ltd. White Knight Co., Ltd. is owned and controlled by Koichi Ishizuka. Koichi Ishizuka is Chief
Executive Officer, Chief Financial Officer, and Director of Dr. Foods, Inc., Mama Foods Co., Ltd. and White Knight Co., Ltd.
Item 9.01  Exhibits.
Exhibit Number
Description of Exhibit
10.1
Letter
    of Intent (1)
(1)
Filed herewith.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dr.
    Foods, Inc.
Dated:
     January 13, 2022
/s/
    Koichi Ishizuka
Koichi Ishizuka
Chief Executive Officer